Vakcíny jsou málo účinné proti mutacím! Chrání ale před těžkým průběhem tn.nova.cz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tn.nova.cz Daily Mail and Mail on Sunday newspapers.
Extra Data Shows AstraZeneca Vaccine Efficacy In Elderly: UK Regulators Extra Data Shows AstraZeneca Vaccine Efficacy In Elderly: UK Regulators Britain has been rolling out the shot among all age groups after the Medicines and Healthcare products Regulatory Agency (MHRA) was the first regulator to approve it in December.
European countries have said more data is needed before it is given to those over 65.
London:
British regulators have received extra trial data from AstraZeneca that supports their view that the COVID-19 vaccine developed with Oxford University is effective in the elderly, a vaccines official said on Friday
Britain has been rolling out the shot among all age groups after the Medicines and Healthcare products Regulatory Agency (MHRA) was the first regulator to approve it in December, but some other European countries have said more data is needed before it is given to those over 65.
British regulators have received extra trial data from AstraZeneca that supports their view that the Covid-19 vaccine developed with Oxford University is effective in the elderly, a vaccines official said on Friday. Britain has been rolling out the shot among all age groups after the Medicines and Healthcare products Regulatory Agency (MHRA) was the first regulator to approve it in December, but some other European countries have said more data is needed before it is given to those over 65. Munir Pirmohamed, Chair of the Commission on Human Medicines Covid-19 Vaccines Benefit Risk Expert Working Group said British regulators had noticed the smaller number of under-65s in the data when they approved the vaccine.
Decision to reject vaccine ‘is between AstraZeneca and Swiss authorities’
(Danny Lawson/PA)
Switzerland’s decision not to authorise use of the University of Oxford’s Covid-19 jab is between the country’s medical regulator and AstraZeneca, a leading vaccine expert has said.
Professor Matthew Snape, an associate professor in paediatrics and vaccinology at the University of Oxford, said the vaccine has been licensed in many countries around the world and given to millions of people.
Speaking on Times Radio, he said: “We have published in peer-review manuscripts the effectiveness of this vaccine.
“The actual filing of the licensure is with AstraZeneca, and that is between AstraZeneca and the Swiss authorities, so I can’t really comment on that.